(-0.41%) 5 046.00 points
(-0.18%) 37 923 points
(-0.75%) 17 440 points
(-1.53%) $80.68
(-2.86%) $1.934
(-0.20%) $2 298.40
(0.15%) $26.70
(0.07%) $948.90
(0.02%) $0.937
(0.20%) $11.12
(0.03%) $0.801
(0.01%) $93.46
-0.99% ¥ 2 500.00
Live Chart Being Loaded With Signals
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies...
Stats | |
---|---|
Dzisiejszy wolumen | 81 900.00 |
Średni wolumen | 61 533.00 |
Kapitalizacja rynkowa | 39.11B |
EPS | ¥0 ( 2024-04-12 ) |
Następna data zysków | ( ¥0 ) 2024-07-11 |
Last Dividend | ¥30.00 ( 2023-05-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 12.03 |
ATR14 | ¥1.285 (0.05%) |
Wolumen Korelacja
Daito Pharmaceutical Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Daito Pharmaceutical Korelacja - Waluta/Towar
Daito Pharmaceutical Finanse
Annual | 2022 |
Przychody: | ¥45.10B |
Zysk brutto: | ¥10.33B (22.91 %) |
EPS: | ¥227.64 |
FY | 2022 |
Przychody: | ¥45.10B |
Zysk brutto: | ¥10.33B (22.91 %) |
EPS: | ¥227.64 |
FY | 2022 |
Przychody: | ¥43.46B |
Zysk brutto: | ¥11.46B (26.36 %) |
EPS: | ¥335.41 |
FY | 2021 |
Przychody: | ¥48.71B |
Zysk brutto: | ¥10.79B (22.16 %) |
EPS: | ¥311.02 |
Financial Reports:
No articles found.
Daito Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥30.00 (N/A) |
¥0 (N/A) |
¥30.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥4.55 | 2010-05-27 |
Last Dividend | ¥30.00 | 2023-05-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 24 | -- |
Total Paid Out | ¥396.45 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.49 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.80 | |
Div. Directional Score | 7.50 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6638.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
5965.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
4662.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
3902.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
3134.T | Ex Dividend Junior | 2024-04-26 | Annually | 0 | 0.00% | |
2004.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8999.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
8550.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7872.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7013.T | No Dividend Player | 2023-09-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0726 | 1.500 | 8.55 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0424 | 1.200 | 8.59 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0639 | 1.500 | -0.402 | -0.602 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.29 | 0.800 | 3.53 | 2.82 | [1 - 3] |
quickRatioTTM | 1.083 | 0.800 | 8.33 | 6.67 | [0.8 - 2.5] |
cashRatioTTM | 0.202 | 1.500 | 9.99 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0944 | -1.500 | 8.43 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 182.83 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 346.01 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 346.01 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.141 | -1.500 | 9.44 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.214 | 1.000 | 9.77 | 9.77 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0930 | 1.000 | -0.139 | -0.139 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.744 | 1.000 | 6.98 | 6.98 | [0.2 - 2] |
assetTurnoverTTM | 0.584 | 0.800 | 9.44 | 7.55 | [0.5 - 2] |
Total Score | 11.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 12.00 | 1.000 | 8.89 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0639 | 2.50 | -0.258 | -0.602 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 346.01 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.28 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 346.01 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.474 | 1.500 | -6.49 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.120 | 1.000 | 9.50 | 0 | [0.1 - 0.5] |
Total Score | 3.80 |
Daito Pharmaceutical
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej